NL-OMON23825
Not Yet Recruiting
N/A
Effects of cardiac telerehabilitation in patients with coronary artery disease using a personalized patient-centred ICT platform: the SmartCare-CAD study.
Máxima Medisch Centrum0 sites300 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Máxima Medisch Centrum
- Enrollment
- 300
- Status
- Not Yet Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 18 or over
- •\- Referral for cardiac rehabilitation due to stable angina pectoris, acute coronary syndrome (with or without ST\-segment elevation) or after coronary revascularization, i.e. (primary or elective) percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)
Exclusion Criteria
- •\- Ventricular arrhythmia or myocardial ischemia during low to moderate exercise intensity as assessed by symptom limited exercise testing at baseline
- •\- Heart failure NYHA class IV
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Effects of cardiac telerehabilitation in patients with coronary artery disease using a personalized patient-centred ICT platform: the SmartCare-CAD studyatherosclerosismyocardial infarction10011082NL-OMON45170Maxima Medisch Centrum300
Unknown
N/A
Cardiac Telerehabilitation Effectiveness Using Wearable SensorsCardiovascular DiseasesCardiac RehabilitationTelerehabilitationNCT05019157Garyfallia Pepera102
Recruiting
N/A
Effects of cardiac rehabilitation in the patients with heart failure -Changing of Muscle mass with exerciseHeart failureJPRN-UMIN000024365Kansai Medical University Hospital200
Completed
N/A
The effect of internet-based cardiac rehabilitation on improving coronary risk factors: A randomized controlled trial.Patients with ischemic heart diseaseJPRN-UMIN000009935agoya University Graduate School of Medicine90
Completed
N/A
Home-based real-time cardiac telerehabilitation: a randomized controlled non-inferiority trialheart diseaseJPRN-UMIN000040657Sakakibara Heart Institute40